BEIJING, Aug. 12,
2022 /PRNewswire/ -- WeTrade Group Inc. ("Wetrade" or
the "Company") (NASDAQ: WETG), an emerging growth company engaged
in the business of providing software-as-a-services (SAAS) and
cloud intelligent systems for micro-businesses, today announced the
Company has entered into a sales agreement (the "Agreement") on
August 11, 2022 with Parkway Medical
Limited ("Parkway Medical") to sell monkeypox virus test kits and
antigen tests for US$50 million.
Pursuant to the Agreement, Parkway Medical agreed to purchase 5
million units of nucleic acid test (RT-LAMP) and 6 million units of
antigen tests (Colloidal Golden Technique) for an aggregate amount
of US$50 million, and Parkway
Medical has paid US$1 million as
deposit.
Mr. Pijun Liu, Chief Executive Officer of the Company,
commented, "We are excited about the sales of monkeypox virus kits
and antigen tests to Parkway Medical after obtaining the exclusive
sales channel from Jiqing Biomedical Technology Co. Ltd. It is
important for us to be efficient so that we can take the lead to
effectively tackle the challenges of the monkeypox outbreak. We are
delighted to work with Parkway Medical to provide the test kits and
antigen tests to overseas market as we aim to contribute to the
prevention and control of the outbreak. With the support of our
developed business ecosystem, we are optimistic about the future of
Wetrade as it will definitely seize business opportunities and
generate strong momentum for our growth."
About WeTrade Group Inc.
WeTrade Group Inc. is a technical service provider of SAAS and
Cloud Intelligent System for micro-businesses, and a pioneering
internationalized system in the global micro-business cloud
intelligence field and the leader, innovator and promoter of the
world's cloud intelligent system for micro-businesses. WeTrade
Group independently developed the cloud intelligent system for
micro-businesses (Abbreviation: YCloud). YCloud strengthens users'
marketing relationship and CPS commission profit management through
leading technology and big data analysis. It also helps increase
the payment scenarios to increase customers' revenue by
multi-channel data statistics, AI fission and management as well as
improved supply chain system. As of today, YCloud's business has
successfully landed in mainland China and Hong
Kong, covering the micro business industry, tourism
industry, hospitality industry, livestreaming and short video
industry, aesthetic medical industry and traditional retail
industry. For more information, please visit
https://ir.wetg.group.
Forward-Looking Statements
This press release contains information about the Company's
view of its future expectations, plans and prospects that
constitute forward-looking statements. Actual results may
differ materially from historical results or those indicated by
these forward-looking statements as a result of a variety of
factors including, but not limited to, risks and uncertainties
associated with its ability to raise additional funding, its
ability to maintain and grow its business, variability of operating
results, its ability to maintain and enhance its brand, its
development and introduction of new products and services, the
successful integration of acquired companies, technologies and
assets into its portfolio of products and services, marketing and
other business development initiatives, competition in the
industry, general government regulation, economic conditions,
dependence on key personnel, the ability to attract, hire and
retain personnel who possess the technical skills and experience
necessary to meet the requirements of its clients, and its ability
to protect its intellectual property. The Company's encourages
you to review other factors that may affect its future results in
the Company's annual reports and in its other filings with the
Securities and Exchange Commission.
View original
content:https://www.prnewswire.com/news-releases/wetrade-group-inc-announces-us50-million-sales-of-monkeypox-virus-test-kits-to-parkway-medical-limited-301604949.html
SOURCE WeTrade Group INC